Annual review of medicine最新文献

筛选
英文 中文
Rethinking Meningioma Biology: Integrating Molecular and Microenvironmental Insights for Mechanism-Guided Therapy. 重新思考脑膜瘤生物学:整合分子和微环境的见解为机制指导治疗。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-11-13 DOI: 10.1146/annurev-med-061826-092908
Chris Z Wei, Mark W Youngblood, Jheremy S Reyes, Maciej S Lesniak, Pouya Jamshidi, David R Raleigh, Amy B Heimberger, Stephen T Magill, Constantinos G Hadjipanayis
{"title":"Rethinking Meningioma Biology: Integrating Molecular and Microenvironmental Insights for Mechanism-Guided Therapy.","authors":"Chris Z Wei, Mark W Youngblood, Jheremy S Reyes, Maciej S Lesniak, Pouya Jamshidi, David R Raleigh, Amy B Heimberger, Stephen T Magill, Constantinos G Hadjipanayis","doi":"10.1146/annurev-med-061826-092908","DOIUrl":"https://doi.org/10.1146/annurev-med-061826-092908","url":null,"abstract":"<p><p>Meningiomas are the most common primary intracranial tumors, accounting for 42.6% of all central nervous system tumors. Although many meningiomas are indolent, clinical behavior is highly heterogeneous, with recurrence occurring in a minority of low-risk tumors but in more than half of clinically high-risk cases despite standard therapy. During the past decade, significant advancements in molecular profiling have provided insights into meningioma biology and have begun to influence clinical practice. Genomic sequencing, DNA methylation profiling, and gene expression analyses have revealed distinct molecular subgroups with prognostic and therapeutic implications. These advancements, coupled with a growing understanding of the meningioma immune microenvironment, have expanded therapeutic possibilities beyond traditional surgery and radiation approaches. Here, we review how molecular profiling is refining patient stratification and treatment selection, examine the evidence supporting various therapeutic approaches, and explore ongoing clinical trials. Finally, we highlight the critical challenges in advancing personalized medicine for meningioma patients. This comprehensive review provides an integrated overview of current diagnostic and treatment paradigms while offering perspectives on future directions in meningioma therapy.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly Evolving Insulin Landscape: Ultrashort Acting and Ultralong Acting. 快速发展的胰岛素格局:超短效和超长效。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-11-12 DOI: 10.1146/annurev-med-042425-010403
Navneet Sohi, Rishi B Gupta, Suhani K Arora, Harpreet S Bajaj
{"title":"Rapidly Evolving Insulin Landscape: Ultrashort Acting and Ultralong Acting.","authors":"Navneet Sohi, Rishi B Gupta, Suhani K Arora, Harpreet S Bajaj","doi":"10.1146/annurev-med-042425-010403","DOIUrl":"https://doi.org/10.1146/annurev-med-042425-010403","url":null,"abstract":"<p><p>Since the discovery of insulin in 1921, there has been remarkable evolution in insulin treatment for diabetes, with modern insulin analogues utilizing highly engineered recombinant technology. The purpose of this review is to focus on two revolutionary developments in contemporary insulin therapy: once-weekly ultralong-acting basal insulins and ultrashort-acting bolus insulins. Insulin icodec and insulin efsitora alfa represent a unique shift in basal insulin delivery, offering the convenience of once-weekly administration, flat pharmacokinetic profiles, and glycemic efficacy and safety comparable to those of daily basal analogues while reducing injection burden and improving patient satisfaction. With regard to bolus therapy, faster-acting aspart and ultrarapid lispro achieve accelerated absorption through novel excipient engineering, enabling more flexible mealtime dosing and improved postprandial glucose control compared to their traditional counterparts. Looking ahead, there are promising innovations on the horizon, including glucose-responsive insulins, artificial intelligence-driven automated insulin delivery, and the continued pursuit of oral insulin. Together, these advances represent an accelerating trajectory toward more physiological, convenient, and, most importantly, safe insulin therapy.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Biologics and Immune Checkpoint Inhibitors During Pregnancy in Patients with Systemic Autoimmune Diseases and Cancer. 妊娠期系统性自身免疫性疾病和癌症患者使用生物制剂和免疫检查点抑制剂
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-11-06 DOI: 10.1146/annurev-med-042425-044110
Brooke S Mills, Bonnie L Bermas
{"title":"Use of Biologics and Immune Checkpoint Inhibitors During Pregnancy in Patients with Systemic Autoimmune Diseases and Cancer.","authors":"Brooke S Mills, Bonnie L Bermas","doi":"10.1146/annurev-med-042425-044110","DOIUrl":"https://doi.org/10.1146/annurev-med-042425-044110","url":null,"abstract":"<p><p>Biologics and immune checkpoint inhibitors have transformed the treatment of autoimmune conditions and cancers. However, safety data regarding use during pregnancy are limited. Clinicians are left to weigh the potential benefits of treatment with frequently unknown risks to the pregnant patient and developing fetus. These therapies do not cross the placenta during the first trimester; thus, they are unlikely to cause teratogenicity. Use later in pregnancy has the potential to immunosuppress the neonate, which could lead to infection and inadequate vaccine response. These large molecules are minimally transferred into breastmilk and are mostly compatible with nursing.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative Management of Kidney Failure. 肾衰竭的保守治疗。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-10-28 DOI: 10.1146/annurev-med-042425-022821
Jordana Yahr, Jane O Schell, Samantha L Gelfand
{"title":"Conservative Management of Kidney Failure.","authors":"Jordana Yahr, Jane O Schell, Samantha L Gelfand","doi":"10.1146/annurev-med-042425-022821","DOIUrl":"https://doi.org/10.1146/annurev-med-042425-022821","url":null,"abstract":"<p><p>The default therapy for end-stage kidney disease is often dialysis, but for those with advanced age and multimorbidity, it may not provide significant benefit to longevity or quality of life. Conservative management (CM) is a holistic care pathway for those whose care preferences do not align with dialysis. CM aims to optimize quality of life over the disease course as patient priorities evolve and their disease progresses. Components of CM include customized chronic kidney disease care, symptom management, and navigation of transitions of care, including end-of-life care. Nephrology clinicians are the central providers of CM and ideally collaborate with a multidisciplinary team to provide medical, psychosocial, and spiritual care.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T Cell Receptor-Engineered T Cell Therapy in Solid Tumors: Where We Stand and What's to Come. T细胞受体工程T细胞治疗在实体肿瘤中的应用:我们的现状和未来。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-10-23 DOI: 10.1146/annurev-med-042425-051841
Candela Ferriol-Martínez, Sandra P D'Angelo
{"title":"T Cell Receptor-Engineered T Cell Therapy in Solid Tumors: Where We Stand and What's to Come.","authors":"Candela Ferriol-Martínez, Sandra P D'Angelo","doi":"10.1146/annurev-med-042425-051841","DOIUrl":"https://doi.org/10.1146/annurev-med-042425-051841","url":null,"abstract":"<p><p>T cell receptor-engineered T (TCR-T) cell therapy has emerged as a promising adoptive cellular therapy for solid tumors by enabling recognition of intracellular antigens presented via human leukocyte antigen (HLA) molecules. Unlike chimeric antigen receptor T cell therapy, TCR-T cell therapy targets a broader antigen repertoire, including cancer-testis antigens, neoantigens, and viral antigens. Recent clinical advances, highlighted by the approval of afamitresgene autoleucel in synovial sarcoma, demonstrate meaningful antitumor activity. However, several limitations remain, including HLA restriction, antigen heterogeneity, toxicity related to on-target/off-tumor effects, and mechanisms of resistance such as antigen loss and T cell exhaustion. Advances in antigen selection, gene editing, and synthetic biology are improving both safety and efficacy. Combination strategies and next-generation engineered constructs are expected to overcome current barriers. This review summarizes the biological rationale, clinical evidence, safety considerations, and resistance mechanisms of TCR-T cell therapy in solid tumors and discusses future directions to optimize their therapeutic potential.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149242656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Risk of an H5N1 Influenza Pandemic. H5N1流感大流行的风险。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-10-16 DOI: 10.1146/annurev-med-042525-092552
James D R Hartley, Anika Singanayagam, Daniel H Goldhill
{"title":"The Risk of an H5N1 Influenza Pandemic.","authors":"James D R Hartley, Anika Singanayagam, Daniel H Goldhill","doi":"10.1146/annurev-med-042525-092552","DOIUrl":"https://doi.org/10.1146/annurev-med-042525-092552","url":null,"abstract":"<p><p>The last 110 years have seen four influenza A pandemics, where viruses have emerged from mammals or birds with the ability to transmit and cause disease in human populations. Since 2021, a high-pathogenicity strain of avian influenza, H5N1, has caused a panzootic (pandemic of animals), with global spread in wild birds, resulting in frequent spillovers into farmed poultry and into mammals, including mammal species not previously known to be affected by influenza A. This has created increased opportunity for reassortment, mutation, human infection, and potential adaptation to transmit. The risk to humans and the impact are difficult to quantify but of mounting concern to public health bodies. Here, we examine the risk of an H5N1 pandemic emerging and spreading in humans and the potential impact of an H5N1 pandemic.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Tricuspid Valve Disease. 三尖瓣疾病的治疗。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-10-01 DOI: 10.1146/annurev-med-042525-084459
Elina Pliakos, Suzanne J Baron
{"title":"Treatment of Tricuspid Valve Disease.","authors":"Elina Pliakos, Suzanne J Baron","doi":"10.1146/annurev-med-042525-084459","DOIUrl":"https://doi.org/10.1146/annurev-med-042525-084459","url":null,"abstract":"<p><p>In the landscape of valvular heart disease, the tricuspid valve has traditionally been dubbed the forgotten valve. However, over the last several years, studies have demonstrated that tricuspid valve disease is increasing in prevalence due to a growing aging population, and tricuspid regurgitation, in particular, is associated with increased mortality and morbidity. Traditional surgical tricuspid valve replacement or repair is often an undesirable option for patients with severe tricuspid regurgitation due to the high rates of concurrent comorbidities seen in this patient population; accordingly, treatment has traditionally been largely confined to symptom management with medical therapy. More recently, however, the field has experienced a major paradigm shift toward transcatheter interventions. Pivotal trials evaluating transcatheter edge-to-edge repair and transcatheter tricuspid valve replacement have shown that these therapies safely achieve robust tricuspid regurgitation reduction, reduce heart failure hospitalization, and significantly improve patient-reported quality of life in the short term. These technologies have been key in providing treatment options for a large, previously underserved patient population, but further research is needed to establish the durability of these devices and to evaluate the cost-effectiveness of these interventions within a value-based healthcare framework.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetics of Obesity: Discovery, Biology, Prediction, and Therapeutic Implications. 肥胖的遗传学:发现、生物学、预测和治疗意义。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-09-30 DOI: 10.1146/annurev-med-060123-120428
Melanie A Babinski, Ruth J F Loos, Sonja I Berndt, Joel N Hirschhorn
{"title":"Genetics of Obesity: Discovery, Biology, Prediction, and Therapeutic Implications.","authors":"Melanie A Babinski, Ruth J F Loos, Sonja I Berndt, Joel N Hirschhorn","doi":"10.1146/annurev-med-060123-120428","DOIUrl":"https://doi.org/10.1146/annurev-med-060123-120428","url":null,"abstract":"<p><p>With the rise in its prevalence, obesity has become a public health threat worldwide. Understanding the genetic and biological origins of obesity is critical for discovering and implementing better prevention and treatment strategies to combat its dominance and impact on disease risk. This review summarizes current knowledge about the genetic architecture of obesity, including the contribution of rare and common variants to monogenic and polygenic forms of obesity. It discusses the biological underpinnings of discovered genetic loci and how these mechanistic insights may suggest new potential therapeutic drug targets. Lastly, it explores how these genetic discoveries may aid in the prediction of future obesity, particularly in children and young adults, and lead to more effective prevention strategies for obesity and related diseases, including cardiovascular disease, type 2 diabetes, and cancer.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence and Radiomics in the Diagnosis and Management of Cancer. 人工智能和放射组学在癌症诊断和治疗中的应用。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-09-18 DOI: 10.1146/annurev-med-042325-094452
Lucas Patel, Albert Song, Albert Hsiao
{"title":"Artificial Intelligence and Radiomics in the Diagnosis and Management of Cancer.","authors":"Lucas Patel, Albert Song, Albert Hsiao","doi":"10.1146/annurev-med-042325-094452","DOIUrl":"10.1146/annurev-med-042325-094452","url":null,"abstract":"<p><p>Imaging is increasingly essential for the diagnosis, prognostication, and management of cancer patients. It is a field in rapid evolution and has the potential to provide noninvasive characterization of malignancy, which remains an important Holy Grail of medicine. Radiomics, which involves the high-throughput assessment of imaging features, aims to transform images into structured phenotypic data. By correlating imaging-derived data with clinical and molecular information, radiomics offers the potential to relate tumor biology to imaging phenotype to improve patient prognostication and management. This review surveys the principles and applications of classical and deep learning-based radiomic approaches in oncology, and it highlights key challenges in robustness and reproducibility that must be addressed to realize the potential of radiomics in clinical practice.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13761957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149001166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic Screening for Infants and Reproductive Adults. 婴儿和育龄成人的基因组筛选。
IF 18.8 1区 医学
Annual review of medicine Pub Date : 2026-09-17 DOI: 10.1146/annurev-med-042425-014721
Stephen F Kingsmore, Martin Delatycki
{"title":"Genomic Screening for Infants and Reproductive Adults.","authors":"Stephen F Kingsmore, Martin Delatycki","doi":"10.1146/annurev-med-042425-014721","DOIUrl":"https://doi.org/10.1146/annurev-med-042425-014721","url":null,"abstract":"<p><p>Recent progress in genomic sequencing, bioinformatics, cloud computation, and artificial intelligence is advancing a more mature understanding of the architecture of childhood genetic diseases. This knowledge and these technologies are enabling expanded genomic screening of infant and reproductive adult populations. With many new disease-modifying and curative therapies in development and approval processes, there exists unparalleled opportunity to identify, treat, and decrease the population burden of genetic disease and transform medical genetics. Broad implementation of genomic population screening, however, requires investments for overcoming remaining evidence gaps and operational challenges, and for delivery in a sustainable manner that is acceptable to parents, prospective parents, and physicians.</p>","PeriodicalId":8056,"journal":{"name":"Annual review of medicine","volume":" ","pages":""},"PeriodicalIF":18.8,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148987786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书